Stem Cell Politics and Progressive Values
By Marcy Darnovsky,
reprint of talk at Take Back America 2006
| 06. 15. 2006
Presentation at Take Back America conference, Washington, DC
My remarks today are about progressive values and the politics of stem cell research, and I have some things to tell you that you may not expect.
We all know that the Bush limits on federal funding of embryonic stem cell research are another case of pandering to the religious right, and we look forward to those restrictions being lifted in a Senate vote soon. And we all hope that stem cell research results in new scientific understandings and new medical treatments.
But if our analysis and understanding were to stop there, we’d be overlooking a number of very important progressive values that we urgently need to bring to the politics of stem cell research. If we continue to let the Right frame stem cell research as simply a question about the moral status of embryos, if we buy into the black-and-white polarized politics that has too often characterized the stem cell debate, we’ll be selling ourselves and our values short, and missing important political opportunities.
My organization, the Center for Genetics...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...